Lifespan Vision Ventures — Full Portfolio

BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.

AI & Machine LearningBiotechDeep TechLongevity

Dr. Peterson

Co-investorsBIBioGenerator VenturesMIMissouri Technology CorporationQUquadraScope Venture Fund

Bolden Therapeutics is a biotechnology company developing therapeutics that promote neurogenesis—the formation of new brain cells—to treat neurological and central nervous system diseases such as Alzheimer's.

BiotechDeep TechProvidence, US

JPJohnny Page(Co-Founder & CEO)inAWAshley Webb(Scientific Founder)JFJustin Fallon(Scientific Founder & Chair of Scientific Advisory Board)Dr. Polsky(Executive Chairman)

Co-investorsSLSlater Technology FundPAPartners Resolute

Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.

BiotechDigital HealthLongevitySan Francisco, US

RMRobin Mansukhani(CEO and Co-Founder)inABAnil Bhushan(Scientific Founder)in

BoardDMDylan Morris(Director)in

Co-investorsAGage1BOBold Capital PartnersCOCornucopian Capital ManagementCRCRV (Charles River Ventures)GAGaingelsLOLong Game+4 more

EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.

BiotechHealthtechMedical DevicesNew York, US

NTNina Tandon(Co-Founder, CEO)inSBSarindr Bhumiratana(Co-Founder)inGVGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)

BoardRLRobert Langer(Director)DZDavid Zhu(Director)in

Co-investorsBEBeresford VenturesCACatalytic Impact FoundationEMEMV CapitalHAHackensack Meridian Health Bear's DenKEKendall Capital PartnersMEMEDA Angels+3 more

Fauna Bio applies AI and computational analysis to its proprietary biobank of data from extreme mammals such as hibernating species to identify drug targets that are conserved across species including humans.

AI & Machine LearningBiotechDeep TechHealthtechEmeryville, US

LGLinda Goodman(Founder)inAshley(CEO)

Co-investorsAGage1FAFarvatn VentureGAGaingelsGRGRIDS CapitalLILifeforce CapitalMEMetaplanet+8 more

General Proximity develops proximity-based technologies for drug discovery and development.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

ACArmand Cognetta(Founder)inMatthias PauthnerCorentine Laurin(Principal Scientist, Medicinal Chemistry)Veronica Fulton(Chief of Staff)Benji Dote(EA)Reen Ramos(EA)

Co-investorsY Y CombinatorAGage1FEFelicis VenturesFRFreemind InvestmentsLOLong GameMAMana Ventures+4 more

Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.

BiotechHealthtechLongevityIrvine, US

Gabriel Nistor(Executive Officer)

BoardTakahide Koda(Director)DKDaniel Kraft(Director)inHKHans Keirstead(Chairman of the Board)

Co-investorsBOBold Capital PartnersJLJLSQUquadraScope Venture FundRERemiges Ventures, Inc.

Integrated Biosciences is a biotech company developing treatments and interventions for aging-related diseases using a combination of medicinal chemistry, biochemistry, aging biology, and artificial intelligence.

AI & Machine LearningBiotechLongevity

DJDaniel J. Anderson(Chief Scientific Officer)inSean Brown(Head of Medicinal Chemistry)inDan Whalen(Head of Biochemistry)inSatotaka Omori(Head of Aging Biology)inAPAlex Peysakhovich(Head of AI)in

Co-investorsSUSutter Hill VenturesPAPage One Ventures

Lift Biosciences develops Immunomodulatory Alpha Neutrophils (IMANs), off-the-shelf neutrophil-lineage cell therapies designed to kill tumor cells and restart anti-tumor immune responses in cancer patients.

BiotechHealthtech

Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders.

AI & Machine LearningBiotechDeep TechLos Altos, US

Mike Horowitz(CEO & Co-founder)JIJustin Ichida(Co-founder)inScott Patterson(CTO & Co-founder)inJoe Wagner(Chief Development Officer)

BoardALAlda Leu Dennis(Director)inNicholas Saccomano(Director)

Co-investorsCACantos VenturesGAGaingelsHAHAWKTAILINInitialized CapitalMAMana VenturesSPSpacecadet Ventures+3 more

Paulex Bio is developing an oral medicine aimed at regenerating beta cells to address the underlying cause of type 1 and type 2 diabetes.

BiotechDigital HealthLa Jolla, US

SMSanjuan Miguel(Chief Executive Officer)in

BoardEdgardo Rayo(Director)Mohammad Hayat(Director)FLFrancisco Leon(Director)in

Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.

BiotechHealthtechLongevitySan Diego, US

NDNoah Davidsohn(CSO, Co-Founder)inDODaniel Oliver(CEO, Co-Founder)inGCGeorge Church(Co-Founder and SAB)DADeborah Ascheim(Chief Medical Officer)in

BoardDZDavid Zhu(Director)in

Co-investorsCOCompanion FundCOConnecticut InnovationsDIDigitalis VenturesGAGaingelsKEKendall Capital PartnersVCVCapital+1 more

Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.

BiotechDeep TechHealthtechLongevitySan Francisco, US

GMGlenn Markov(Founder)inJRJohn Ramunas(Founder)inWOWill Olsen(Vice President Of Development)in

Co-investorsASAsymmetry VenturesGOGold Dragon VenturesSTStartupsSTStartXY Y CombinatorAGAgrolimen Ventures+7 more

Remedium Bio is a biotech company developing gene therapy and biologic treatments for osteoarthritis and other rheumatology and metabolic conditions, drawing on research into cartilage regeneration and the FGF18 protein.

BiotechHealthtechLongevityBoston, US

Luppino Francesco(Executive Officer, Director)

Co-investorsULUlu VenturesHKHKX Capital

SENISCA is a University of Exeter biotech developing RNA-based senotherapeutics that target dysregulated RNA splicing to reverse cellular senescence and treat age-related disease.

BiotechDeep TechLongevity

LHLorna Harries(Founder)in

Co-investorsAPAPEX VenturesR4R42 Group

Sift Biosciences develops T-cell immunotherapies for cancer and autoimmune diseases, using an AI-driven discovery platform combined with metagenomics and high-throughput cellular screening to identify microbially derived molecules that activate memory T cells.

AI & Machine LearningBiotechHealthtechSan Carlos, US

YCYue Clare Lou(Co-Founder & CEO)in

BoardKBKevin Barrett(Director)inAltar Munis(Director)

Co-investorsEIEisai Innovation, Inc.SBSBI HoldingsFIFifty YearsFRFREEFLOW

TECregen develops regenerative biologic therapies aimed at thymus regeneration and restoring immune function, using ligand engineering, targeted delivery, and functional screening.

BiotechHealthtechLongevity

Co-investorsBOBoehringer Ingelheim Venture Fund

Violet is a therapeutics company developing small molecule treatments for central nervous system diseases, using its proprietary C-to-C Engine platform to identify disease-relevant cell-to-cell interactions.

BiotechDeep TechCambridge, US

William E Yelle(Executive Officer, Director)Atsushi Usami(Director)Meredith Fisher(Executive Officer, Director)Jonathan Behr(Director)

Co-investorsDEDementia DiscoveryDEDementia Discovery FundONOno Venture Investment, Inc.SVSV Health InvestorsUTUTEC